Partner Jeffrey Fessler Represents ContraVir Pharmaceuticals, Inc. on $7.0 Million Public Offering of Common Stock and Warrants

Press Release – New York, NY – April 5, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the Firm has represented ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on

the development and commercialization of targeted antiviral therapies, on an underwritten public offering of 4,929,578 shares of the Company’s common stock and warrants to purchase up to 2,464,789 shares of common stock at a combined public offering price of $1.42. ContraVir raised $7,000,000 in gross proceeds. Laidlaw & Company (UK) Ltd. was the sole book-running manager for the offering.

The Sichenzia Ross Friedman Ference LLP team was led by Partners Jeffrey J. Fessler and Stephen A. Cohen.

• Author
• Recent Posts

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.

Visit SRF's LinkedIn page

Latest posts by Sichenzia Ross Ference LLP (see all)

• Sichenzia Ross Ference LLP Represents Beyond Air, Inc. in a $11.5 Million Underwritten Public Offering of Common Stock and Concurrent Private Placement - December 13, 2019
• Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in a $115 Million Underwritten Public Offering of Common Stock - December 6, 2019
• Sichenzia Ross Ference Trust & Estate Attorneys Quoted in LegalZoom Article - December 6, 2019